These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. Malik R; Chang M; Bhaskar K; Nasser I; Curry M; Schuppan D; Byrnes V; Afdhal N J Gastroenterol Hepatol; 2009 Apr; 24(4):564-8. PubMed ID: 19378390 [TBL] [Abstract][Full Text] [Related]
15. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects. Ampuero J; Aller R; Gallego-Durán R; Crespo J; Abad J; González-Rodríguez Á; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Martín-Mateos R; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Hernández-Guerra M; Augustín S; Pareja-Megia MJ; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero-Gómez M; Liver Int; 2021 Sep; 41(9):2076-2086. PubMed ID: 33896100 [TBL] [Abstract][Full Text] [Related]
16. Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression. Ekstedt M; Franzén LE; Mathiesen UL; Kechagias S Scand J Gastroenterol; 2012 Jan; 47(1):108-15. PubMed ID: 22126450 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis. Pelusi S; Cespiati A; Rametta R; Pennisi G; Mannisto V; Rosso C; Baselli G; Dongiovanni P; Fracanzani AL; Badiali S; Maggioni M; Craxi A; Fargion S; Prati D; Nobili V; Bugianesi E; Romeo S; Pihlajamaki J; Petta S; Valenti L Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2310-2319.e6. PubMed ID: 30708111 [TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Younossi ZM; Gramlich T; Liu YC; Matteoni C; Petrelli M; Goldblum J; Rybicki L; McCullough AJ Mod Pathol; 1998 Jun; 11(6):560-5. PubMed ID: 9647594 [TBL] [Abstract][Full Text] [Related]
19. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Fukusato T World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438 [TBL] [Abstract][Full Text] [Related]
20. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. Xanthakos S; Miles L; Bucuvalas J; Daniels S; Garcia V; Inge T Clin Gastroenterol Hepatol; 2006 Feb; 4(2):226-32. PubMed ID: 16469684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]